Born and raised in the Greek capital Athens, and having spent her life between London and Naples, Professor Papaemmanouil decided to follow her academic career in the field of molecular genetics and studied at the University of Glasgow.
After graduating she received a doctoral scholarship at the London Cancer Research Foundation. And here she conducted research on the genetic predisposition for colorectal cancer and childhood leukemia.
As head of the research group, she identified the first gene locus associated with the increased risk of developing childhood leukemia. The conclusion of the research on myelodysplasia is that new, introspective jottings would facilitate the genetic screening mutation.
Later on, Dr. Elli Papaemmanouil worked in the Wellcome Trust Sanger Genome Campus of Cambridge University, one of the leading genome research institutes in the world.
From 2010 until 2014, she worked as a senior postdoctoral researcher at the Wellcome Trust Sanger Institute. From 2014 until today, the Greek scientist works as a team leader at the University of Cambridge.
Since March 2015, she is also an assistant professor at the Memorial Sloan Kettering Cancer Center (MSKCC).
Professor Papaemannouil also coordinates centers in more than 30 countries, where they collect and test tens of thousands of samples covering all forms of myelogenous and lymphocytic leukemia.
Source: greekcitytimes.com